The activating molecules, CD40 and TLR8 ligand, seemed to enhance T cell proliferation for both CD8+ and CD4+ T cells co-cultured with tumor cells, fibroblasts and spheroid polarized MDMs stronger than the inhibiting molecules (Fig 8). This evidence concerns the gene CD8A and neoplasm.